Webinar Feb. 10: Addressing Social Needs to Prevent and Reduce Cancer


Take Action Webinar
Share On Social!

Many cancer patients in South Texas and beyond experience barriers in access to health care, insurance, immigration status, affordable housing, transportation, education, as well as cultural and linguistic barriers. This can dramatically impact their cancer outcomes.

To address this issue, you’re invited to join us for “Addressing Social Needs in Efforts to Prevent and Reduce Cancer” at 1 p.m. CST on Feb. 10, 2022.

This is the second webinar of a new series, “Let’s Address Health Equity Together.”

This Zoom webinar will show how health care leaders can participate in advocacy for policy and system changes that address these health inequities and social needs, beyond providing more sensitive care and/or research.

“This webinar will help doctors, nurses, researchers and other healthcare professionals meet the social needs and address barriers to access to care in South Texas and beyond,” said Dr. Amelie Ramirez, leader of Salud America! at UT Health San Antonio, who is the moderator for the webinar.

watch the recording!

Learn about the Webinar Panelists on Latinos and Clinical Trials

On Feb. 10, 2022, panelists Dr. Luz Garcini, Kyle DeLeon, and Dolores Garcia, will present on the social needs of cancer patients in South Texas, with a discussion and question-and-answer session moderated by Dr. Amelie Ramirez.

Dr. Amelie G. Ramirez, an internationally recognized researcher in Latino health promotion and behavioral change, is director of Salud America! and its home base, the Institute for Health Promotion Research in the Department of Population Health Sciences at UT Health San Antonio. She has spent over 30 years directing research on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos, including cancer risk factors, clinical trial recruitment, tobacco prevention, obesity prevention, and promotion of health equity. She also is associate director of cancer outreach and engagement at the NCI-designated Mays Cancer Center at UT Health San Antonio.

Dr. Luz Garcini is a clinical psychologist and an Assistant Professor at the Center for Research to Advance Community Health (ReACH) at UT Health San Antonio with a joint appointment in the Department of Medicine and the Department of Psychiatry. Read more about her at salud.to/latinogrief.

Kyle DeLeon is the Texas Grassroots Manager for the American Cancer Society Cancer Action Network, building communities of volunteers across the state and training them to have productive conversations with lawmakers at every level of government to take actionable steps in reducing the burden of cancer. After 3 rounds of BEP chemotherapy In 2018, Kyle survived stage II testicular cancer (the same cancer that took the life of his paternal grandfather). He proudly draws upon his experience as a survivor to advocate for other cancer patients and their families.

Dolores Garcia is a Research Area Specialist at the Institute of Health Promotion Research of UT Health San Antonio. She has previously worked as a Health Educator and Community Health Worker, working closely with the Latino communities of South Texas.

watch the recording!

Behind the Webinar Series on Health Equity

The “Let’s Address Health Equity Together” webinar series is a collaboration of the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio, the Mays Cancer Center at UT Health San Antonio, and Genentech.

Salud America! is a national Latino-focused organization that creates culturally relevant and research-based stories, videos, and tools to inspire people to start and support healthy changes to policies, systems, and environments where Latino children and families can equitably live, learn, work, and play.

The Mays Cancer Center, also known as the UT Health San Antonio MD Anderson Cancer Center, has a mission to decrease the burden of cancer in San Antonio, South Texas and beyond. We bring South Texas a level of exceptional care that is comparable with the nation’s most respected programs. More patients put their trust in our program because we have a unique understanding of our community’s cancer care needs. We excel in delivering advanced therapies.

Founded more than 40 years ago as the first biotechnology company, Genentech is dedicated to the rigorous pursuit of science and the development and delivery of life-changing medicines for people facing serious diseases. Headquartered in South San Francisco, California and a proud member of the Roche Group, our community is united by a common purpose and sense of urgency to transform the future of healthcare. Learn more at gene.com.

watch the recording!

Explore More:

Cancer, Healthcare Access

By The Numbers By The Numbers



Expected rise in Latino cancer cases in coming years

Share your thoughts